Roxane Settles Price Inflation Suit For $1.8M

Law360, New York (September 22, 2008, 12:00 AM EDT) -- Generic-drug maker Boehringer Ingelheim Roxane Inc. has agreed to pay Massachusetts' state Medicaid program $1.8 million to settle a lawsuit alleging that it defrauded the program by overstating the cost of drugs.

Roxane is one of 13 generics makers that were sued by the Commonwealth of Massachusetts in 2003 under the False Claims Act for allegedly reporting inflated drug prices to national price-reporting services. State Medicaid programs use prices reported by pharmaceutical companies to determine how much they will pay for drugs given to Medicaid recipients....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.